TY - JOUR AU - Moher, D. AU - Hopewell, S. AU - Schulz, K. F. AU - Montori, V. AU - Gøtzsche, P. C. AU - Devereaux, P. J. AU - Elbourne, D. AU - Egger, M. AU - Altman, D. G. PY - 2010 DA - 2010// TI - CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials JO - BMJ. VL - 340 UR - https://doi.org/10.1136/bmj.c869 DO - 10.1136/bmj.c869 ID - Moher2010 ER - TY - JOUR AU - Rothman, K. J. PY - 1978 DA - 1978// TI - A show of confidence JO - N Engl J Med. VL - 299 UR - https://doi.org/10.1056/NEJM197812142992410 DO - 10.1056/NEJM197812142992410 ID - Rothman1978 ER - TY - JOUR AU - Gardner, M. J. AU - Altman, D. G. PY - 1986 DA - 1986// TI - Confidence intervals rather than P values: estimation rather than hypothesis testing JO - Br Med J (Clin Res Ed) VL - 292 UR - https://doi.org/10.1136/bmj.292.6522.746 DO - 10.1136/bmj.292.6522.746 ID - Gardner1986 ER - TY - JOUR AU - Cummings, P. AU - Koepsell, T. D. PY - 2010 DA - 2010// TI - P values vs estimates of association with confidence intervals JO - Arch Pediatr Adolesc Med. VL - 164 ID - Cummings2010 ER - TY - JOUR AU - Chavalarias, D. AU - Wallach, J. D. AU - Li, A. H. T. AU - Ioannidis, J. P. A. PY - 2016 DA - 2016// TI - Evolution of reporting P values in the biomedical literature, 1990-2015 JO - JAMA. VL - 315 UR - https://doi.org/10.1001/jama.2016.1952 DO - 10.1001/jama.2016.1952 ID - Chavalarias2016 ER - TY - JOUR AU - McCormack, J. AU - Vandermeer, B. AU - Allan, G. M. PY - 2013 DA - 2013// TI - How confidence intervals become confusion intervals JO - BMC Med Res Methodol VL - 13 UR - https://doi.org/10.1186/1471-2288-13-134 DO - 10.1186/1471-2288-13-134 ID - McCormack2013 ER - TY - JOUR AU - Boutron, I. AU - Dutton, S. AU - Ravaud, P. AU - Altman, D. G. PY - 2010 DA - 2010// TI - Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes JO - JAMA VL - 303 UR - https://doi.org/10.1001/jama.2010.651 DO - 10.1001/jama.2010.651 ID - Boutron2010 ER - TY - JOUR AU - Lockyer, S. AU - Hodgson, R. AU - Dumville, J. C. AU - Cullum, N. PY - 2013 DA - 2013// TI - “Spin” in wound care research: the reporting and interpretation of randomized controlled trials with statistically non-significant primary outcome results or unspecified primary outcomes JO - Trials. VL - 14 UR - https://doi.org/10.1186/1745-6215-14-371 DO - 10.1186/1745-6215-14-371 ID - Lockyer2013 ER - TY - JOUR AU - Patel, S. V. AU - Koughnett, J. A. AU - Howe, B. AU - Wexner, S. D. PY - 2015 DA - 2015// TI - spin is common in studies assessing robotic colorectal surgery: an assessment of reporting and interpretation of study results JO - Dis Colon Rectum VL - 58 UR - https://doi.org/10.1097/DCR.0000000000000425 DO - 10.1097/DCR.0000000000000425 ID - Patel2015 ER - TY - JOUR AU - Patel, S. V. AU - Chadi, S. A. AU - Choi, J. AU - Colquhoun, P. H. PY - 2013 DA - 2013// TI - The use of “spin” in laparoscopic lower GI surgical trials with nonsignificant results: an assessment of reporting and interpretation of the primary outcomes JO - Dis Colon Rectum VL - 56 UR - https://doi.org/10.1097/01.dcr.0000436466.50341.c5 DO - 10.1097/01.dcr.0000436466.50341.c5 ID - Patel2013 ER - TY - JOUR AU - Moher, D. AU - Liberati, A. AU - Tetzlaff, J. AU - Altman, D. G. PY - 2009 DA - 2009// TI - Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement JO - BMJ. VL - 339 UR - https://doi.org/10.1136/bmj.b2535 DO - 10.1136/bmj.b2535 ID - Moher2009 ER - TY - JOUR AU - Als-Nielsen, B. AU - Chen, W. AU - Gluud, C. AU - Kjaergard, L. L. PY - 2003 DA - 2003// TI - Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JO - JAMA VL - 290 UR - https://doi.org/10.1001/jama.290.7.921 DO - 10.1001/jama.290.7.921 ID - Als-Nielsen2003 ER - TY - JOUR AU - Moher, D. AU - Dulberg, C. S. AU - Wells, G. A. PY - 1994 DA - 1994// TI - Statistical power, sample size, and their reporting in randomized controlled trials JO - JAMA VL - 272 UR - https://doi.org/10.1001/jama.1994.03520020048013 DO - 10.1001/jama.1994.03520020048013 ID - Moher1994 ER - TY - JOUR AU - Cannon, C. P. AU - Blazing, M. A. AU - Giugliano, R. P. AU - McCagg, A. AU - White, J. A. AU - Theroux, P. AU - Darius, H. AU - Lewis, B. S. AU - Ophuis, T. O. AU - Jukema, J. W. AU - Ferrari, G. M. AU - Ruzyllo, W. AU - Lucca, P. AU - Im, K. AU - Bohula, E. A. AU - Reist, C. AU - Wiviott, S. D. AU - Tershakovec, A. M. AU - Musliner, T. A. AU - Braunwald, E. AU - Califf, R. M. PY - 2015 DA - 2015// TI - ezetimibe added to statin therapy after acute coronary syndromes JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1410489 DO - 10.1056/NEJMoa1410489 ID - Cannon2015 ER - TY - JOUR AU - Zinman, B. AU - Wanner, C. AU - Lachin, J. M. AU - Fitchett, D. AU - Bluhmki, E. AU - Hantel, S. AU - Mattheus, M. AU - Devins, T. AU - Johansen, O. E. AU - Woerle, H. J. AU - Broedl, U. C. AU - Inzucchi, S. E. PY - 2015 DA - 2015// TI - Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1504720 DO - 10.1056/NEJMoa1504720 ID - Zinman2015 ER - TY - JOUR AU - Jarcho, J. A. AU - Keaney, J. F. PY - 2015 DA - 2015// TI - Proof that lower is better--LDL cholesterol and IMPROVE-IT JO - N Engl J Med. VL - 372 UR - https://doi.org/10.1056/NEJMe1507041 DO - 10.1056/NEJMe1507041 ID - Jarcho2015 ER - TY - JOUR AU - Grant, P. J. PY - 2015 DA - 2015// TI - Empagliflozin in diabetes: a therapeutic light at the end of the cardiovascular tunnel? JO - Diab Vasc Dis Res VL - 12 UR - https://doi.org/10.1177/1479164115611320 DO - 10.1177/1479164115611320 ID - Grant2015 ER - TY - JOUR AU - Taylor, F. AU - Huffman, M. D. AU - Macedo, A. F. AU - Moore, T. H. AU - Burke, M. AU - Davey Smith, G. AU - Ward, K. AU - Ebrahim, S. PY - 2013 DA - 2013// TI - Statins for the primary prevention of cardiovascular disease JO - Cochrane Database Syst Rev. VL - 1 ID - Taylor2013 ER - TY - JOUR AU - Hackshaw, A. AU - Kirkwood, A. PY - 2011 DA - 2011// TI - Interpreting and reporting clinical trials with results of borderline significance JO - BMJ. VL - 343 UR - https://doi.org/10.1136/bmj.d3340 DO - 10.1136/bmj.d3340 ID - Hackshaw2011 ER -